StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
CALA opened at $0.00 on Friday. Calithera Biosciences has a 1 year low of $0.00 and a 1 year high of $0.12.
About Calithera Biosciences
Featured Articles
- Five stocks we like better than Calithera Biosciences
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- What is a SEC Filing?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- 3 Fintech Stocks With Good 2021 Prospects
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.